Dr. Anupam Jena, scientific advisor for Precision Xtract, recently spoke with HealthEconomics.Com Founder and CEO Dr. Patti Peeples about his latest research with Precision Xtract in which he expands on establishing value of novel therapies.
In this new white paper, “What do Value Assessments Miss? Rethinking Value Using New Health Economics Evidence,” Jena takes a deep dive into the definition of value, and explores how it “goes beyond quality and cost of care to include other important dimensions.”
“As drug prices continue to climb and our society wrestles with paying for novel therapies, my colleagues and I have explored how value assessment approaches need to be reconsidered,” Jena told Peeples.
To read the full discussion, click here.